Better predict pharmacokinetic (PK) and drug-drug interactions (DDIs) with DMPK/ADME studies and computational modeling on your compound, prior to clinical trials, to move quickly from discovery to development.
OPPTS 870.7600: Dermal penetration
Human pharmacokinetics (PK) prediction
Population pharmacokinetic (PopPK) modeling
Cerebrospinal fluid (CSF) sampling
Physiologically based pharmacokinetics (PBPK) modeling
Quantitative and/or systems pharmacology (QSP/SP) modeling
Enzyme identification (selective inhibitors & recombinant enzymes)
Drug-Drug Interaction (DDI) modeling
Pharmacokinetic/pharmacodynamic (PK/PD) modeling
Ex vivo enzyme induction for metabolic quality investigation
In vitro cytochrome (CYP) induction
Compartmental & non-compartmental PK/TK analysis
Screening pharmacokinetics (fast PK)
Bioavailability, bioequivalence and biosimilars modeling
In vivo pharmacokinetics (PK)
Let's start a conversation
Contact Us
Labcorp is a leading global life sciences company that includes contract research and developmental services to the pharmaceutical, medical technology, crop protection and chemical industries.
.png){kind=icon}